New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Twist Bioscience Corporation
TWST
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

3B

Medical - Diagnostics & Research

Next Earning date - 31 Jan 2025

3B

Medical - Diagnostics & Research

Next Earning date - 31 Jan 2025

51.48USD
Shape1.03 ( 2.05%)
favorite-chart

Relative Strenght

84
favorite-chart

Volume Buzz

-97%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

15%

Quote Panel

Shape
Updated January 22, 2025
1W 9.98 % 1M 4.84 % 3M 22.78 % 1Y 46.66 %

Key Metrics

Shape
  • Market Cap

    3.07B


  • Shares Outstanding

    59.58M


  • Share in Float

    56.27M


  • Dividende

    0


  • Earning Date

    31 Jan 2025


  • Price Target

    51.485


  • Average Volume

    800900


  • Beta

    1.781


  • Range

    27.41-60.9


  • Industry

    Medical - Diagnostics & Research


  • Website

    https://www.twistbioscience.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

TWST

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$373M

Shape341%

2025-Revenue

$2.25

Shape-282%

2025-EPS

$315M

Shape-1021%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

Guggenheim

initialise

Previous: Not converted

2024-06-04

Now: Buy

Goldman Sachs

upgrade

Previous: Neutral

2024-01-17

Now: Buy

Scotiabank

initialise

Previous: Not converted

2023-01-05

Now: Sector Outperform

Evercore ISI

upgrade

Previous: Not converted

2023-01-03

Now: Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.74
vs -0.91

Q1.23

arrow
arrow

N/A

-1.06
vs -1.24

Q2.23

arrow
arrow

N/A

-1.01
vs -1.08

Q3.23

arrow
arrow

N/A

-0.81
vs -0.91

Q4.23

arrow
arrow

N/A

-0.75
vs -0.74

Q1.24

arrow
arrow

N/A

-0.79
vs -1.06

Q2.24

arrow
arrow

N/A

-0.86
vs -1.01

Q3.24

arrow
arrow

+100%

NA
vs -0.81

Q4.24

arrow
arrow

N/A

-0.63
vs -0.75

Q1.25

arrow
arrow

N/A

-0.61
vs -0.79

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+29%

54.2M  vs 42M

Q1.23

arrow
arrow

+25%

60.2M  vs 48.1M

Q2.23

arrow
arrow

+14%

63.7M  vs 56.1M

Q3.23

arrow
arrow

+17%

66.9M  vs 57.3M

Q4.23

arrow
arrow

+32%

71.5M  vs 54.2M

Q1.24

arrow
arrow

+25%

75.3M  vs 60.2M

Q2.24

arrow
arrow

+28%

81.5M  vs 63.7M

Q3.24

arrow
arrow

+27%

84.7M  vs 66.9M

Q4.24

arrow
arrow

+22%

87M  vs 71.5M

Q1.25

arrow
arrow

+21%

90.9M  vs 75.3M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-6%

-0.06
vs -0.06

Q1.23

arrow
arrow

-8%

-0.08
vs -0.06

Q2.23

arrow
arrow

-9%

-0.09
vs -0.08

Q3.23

arrow
arrow

-7%

-0.07
vs -0.09

Q4.23

arrow
arrow

-7%

-0.07
vs -0.07

Q1.24

arrow
arrow

-8%

-0.08
vs -0.07

Q2.24

arrow
arrow

-17%

-0.17
vs -0.08

Q3.24

arrow
arrow

-7%

-0.07
vs -0.17

Institutionnal OwnershipShape

status-upQoQ

Q4.22

arrow
arrow

204

204
vs 227

-10%

Q1.23

arrow
arrow

207

207
vs 204

1%

Q2.23

arrow
arrow

200

200
vs 207

-3%

Q3.23

arrow
arrow

202

202
vs 200

1%

Q4.23

arrow
arrow

227

227
vs 202

12%

Q1.24

arrow
arrow

245

245
vs 227

8%

Q2.24

arrow
arrow

269

269
vs 245

10%

Q3.24

arrow
arrow

246

246
vs 269

-9%

Earnings Growth

Latest News